Human interleukin-2 receptor β mutations associated with defects in immunity and peripheral tolerance
Open Access
- 30 April 2019
- journal article
- research article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 216 (6) , 1311-1327
Abstract
Interleukin-2, which conveys essential signals for immunity, operates through a heterotrimeric receptor. Here we identify human interleukin-2 receptor (IL-2R) β chain (IL2RB) gene defects as a cause of life-threatening immune dysregulation. We report three homozygous mutations in the IL2RB gene of eight individuals from four consanguineous families that cause disease by distinct mechanisms. Nearly all patients presented with autoantibodies, hypergammaglobulinemia, bowel inflammation, dermatological abnormalities, lymphadenopathy, and cytomegalovirus disease. Patient T lymphocytes lacked surface expression of IL-2Rβ and were unable to respond to IL-2 stimulation. By contrast, natural killer cells retained partial IL-2Rβ expression and function. IL-2Rβ loss of function was recapitulated in a recombinant system in which IL2RB mutations caused reduced surface expression and IL-2 binding. Stem cell transplant ameliorated clinical symptoms in one patient; forced expression of wild-type IL-2Rβ also increased the IL-2 responsiveness of patient T lymphocytes in vitro. Insights from these patients can inform the development of IL-2–based therapeutics for immunological diseases and cancer.Keywords
All Related Versions
Funding Information
- Wellcome Trust (083650/Z/07/Z, 207556/Z/17/Z, 101908/Z/13/Z, 099966/Z/12/Z)
- Division of Intramural Research
- National Institutes of Health
- UK National Institute of Health Research Cambridge Biomedical Research Centre
- Sir Jules Thorn Charitable Trust (12/JTA)
- National Institutes of Health
- National Institutes of Health
- Harvard Medical School
- Deutsche Forschungsgemeinschaft (GO2955/1-1)
This publication has 41 references indexed in Scilit:
- IL15 Infusion of Cancer Patients Expands the Subpopulation of Cytotoxic CD56bright NK Cells and Increases NK-Cell Cytokine Release CapabilitiesCancer Immunology Research, 2017
- GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputersSoftwareX, 2015
- Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent functionBlood, 2012
- The role of interleukin-2 during homeostasis and activation of the immune systemNature Reviews Immunology, 2012
- Competing feedback loops shape IL-2 signaling between helper and regulatory T lymphocytes in cellular microenvironmentsProceedings of the National Academy of Sciences, 2010
- CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked–like syndrome, and defective IL-10 expression from CD4 lymphocytesJournal of Allergy and Clinical Immunology, 2007
- Regulatory CD56brightnatural killer cells mediate immunomodulatory effects of IL-2Rα-targeted therapy (daclizumab) in multiple sclerosisProceedings of the National Academy of Sciences, 2006
- Selective Stimulation of T Cell Subsets with Antibody-Cytokine Immune ComplexesScience, 2006
- IL-2 administration increases CD4+CD25hi Foxp3+ regulatory T cells in cancer patientsBlood, 2006
- Coot: model-building tools for molecular graphicsActa Crystallographica Section D Structural Biology, 2004